Old Web
English
Sign In
Acemap
>
authorDetail
>
Ann-Marie Hulstine
Ann-Marie Hulstine
Melanoma
T cell
Dosing
Cancer research
Medicine
3
Papers
44
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Redirected T cell lysis in patients with metastatic uveal melanoma with gp100-directed TCR IMCgp100: Overall survival findings.
2018
Journal of Clinical Oncology
Takami Sato
Paul D. Nathan
Leonel F. Hernandez-Aya
Joseph J Sacco
Marlana Orloff
Jennifer Visich
Nicola Little
Ann-Marie Hulstine
Christina M. Coughlin
Richard D. Carvajal
Show All
Source
Cite
Save
Citations (26)
Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector IMCgp100 in advanced uveal melanoma
2017
Investigative Ophthalmology & Visual Science
Richard D. Carvajal
Joseph J Sacco
Paul C. Nathan
Marlana Orloff
Nicola Little
Cheryl McAlpine
David Krige
Namir J. Hassan
Ann-Marie Hulstine
Christina M. Coughlin
Takami Sato
Show All
Source
Cite
Save
Citations (4)
Intra-patient escalation dosing strategy with IMCgp100 results in mitigation of T-cell based toxicity and preliminary efficacy in advanced uveal melanoma.
2017
Journal of Clinical Oncology
Takami Sato
Paul D. Nathan
Leonel F. Hernandez-Aya
Joseph J Sacco
Marlana Orloff
Jessica Truscello
Cheryl McAlpine
Ann-Marie Hulstine
Mark C. Lanasa
Christina M. Coughlin
Richard D. Carvajal
Show All
Source
Cite
Save
Citations (14)
1